Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen Pan

Showing results (631-640 of 671) with videos related to

Pageof 68
Sort By:
Pathology|July 8, 2019
Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementationJohn R Srigley, Brett Delahunt, Hemamali Samaratunga, et al.
The Biochemical Journal|March 6, 2014
Calreticulin activates β1 integrin via fucosylation by fucosyltransferase 1 in J82 human bladder cancer cellsYi-Chien Lu, Chiung-Nien Chen, Chia-Ying Chu, et al.
World Journal of Gastroenterology|March 12, 2005
Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressedChueh-Chuan Yen, Yann-Jang Chen, Chin-Chen Pan, et al.
Eclinicalmedicine|November 5, 2024
Development of fully automated models for staging liver fibrosis using non-contrast MRI and artificial intelligence: a retrospective multicenter studyChunli Li, Yuan Wang, Ruobing Bai, et al.
Human Pathology|October 23, 2025
Genitourinary mesenchymal neoplasms with tumor-defining genetic alterations: A clinicopathologic and molecular correlative study of 71 casesChih-Chi Chou, Jen-Chieh Lee, Pao-Shu Wu, et al.
BMC Gastroenterology|May 4, 2019
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in ChinaJian Sun, Huiguo Ding, Guofeng Chen, et al.
Alimentary Pharmacology & Therapeutics|January 5, 2024
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infectionNa-Ling Kang, Lu-Ying Wu, Qi Zheng, et al.
Nature Materials|April 25, 2024
On-device phase engineeringXiaowei Liu, Junjie Shan, Tianjun Cao, et al.
American Journal of Cancer Research|October 11, 2023
REST-repressed lncRNA LINC01801 induces neuroendocrine differentiation in prostate cancer via transcriptional activation of autophagyChing-Hsin Chang, Ting-Yu Cheng, Wayne W Yeh, et al.
Exploration (Beijing, China)|June 30, 2025
Cancer Immunotherapy Based on the Bidirectional Reprogramming of the Tumor Microenvironment by a "Brakes Off/ Step on the Accelerator" Core-Shell Manganese Phosphate/siPD-L1 ModulatorFei Xia, Yuqian Lu, Zipeng Gong, et al.
Pageof 68

Showing results (631-640 of 671) with videos related to

Sort By:
Pageof 68
Pathology|July 8, 2019
Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementationJohn R Srigley, Brett Delahunt, Hemamali Samaratunga, et al.
The Biochemical Journal|March 6, 2014
Calreticulin activates β1 integrin via fucosylation by fucosyltransferase 1 in J82 human bladder cancer cellsYi-Chien Lu, Chiung-Nien Chen, Chia-Ying Chu, et al.
World Journal of Gastroenterology|March 12, 2005
Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressedChueh-Chuan Yen, Yann-Jang Chen, Chin-Chen Pan, et al.
Eclinicalmedicine|November 5, 2024
Development of fully automated models for staging liver fibrosis using non-contrast MRI and artificial intelligence: a retrospective multicenter studyChunli Li, Yuan Wang, Ruobing Bai, et al.
Human Pathology|October 23, 2025
Genitourinary mesenchymal neoplasms with tumor-defining genetic alterations: A clinicopathologic and molecular correlative study of 71 casesChih-Chi Chou, Jen-Chieh Lee, Pao-Shu Wu, et al.
BMC Gastroenterology|May 4, 2019
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in ChinaJian Sun, Huiguo Ding, Guofeng Chen, et al.
Alimentary Pharmacology & Therapeutics|January 5, 2024
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infectionNa-Ling Kang, Lu-Ying Wu, Qi Zheng, et al.
Nature Materials|April 25, 2024
On-device phase engineeringXiaowei Liu, Junjie Shan, Tianjun Cao, et al.
American Journal of Cancer Research|October 11, 2023
REST-repressed lncRNA LINC01801 induces neuroendocrine differentiation in prostate cancer via transcriptional activation of autophagyChing-Hsin Chang, Ting-Yu Cheng, Wayne W Yeh, et al.
Exploration (Beijing, China)|June 30, 2025
Cancer Immunotherapy Based on the Bidirectional Reprogramming of the Tumor Microenvironment by a "Brakes Off/ Step on the Accelerator" Core-Shell Manganese Phosphate/siPD-L1 ModulatorFei Xia, Yuqian Lu, Zipeng Gong, et al.
Pageof 68